Sahar Alee Koloukani, Ailin Cao and Qi Cao
Trans hepatic arterial radioembolotherapy using yttrium-90 microspheres represents in situ therapy in hepatocellular cancer, which is the third leading cause of cancer-related deaths in the world. This therapy shows interesting results in the treatment of these patients. This review focuses on clinical application, advantages, sideeffects and toxicity, and contradictions of the radioembolization treatment program.
この記事をシェアする